Search studies using keywords
1,851 Studies in the database containing data with -log p ≥ 0 (showing 461-480)
Pages: << 21 22 23 24 25 26 27 28 29 30 >>
No data sets (in No Studies) added to Browser
Identifier Name Phenotype(s) Total p-values Related citationsAdd data sets to Browser Related data
HGVST1386 plus GWAS of Periodontal microbiota 
  • Periodontal microbiota (Orange)
  • Periodontal microbiota (A. actino)
  • Periodontal microbiota (P. gingi)
  • Periodontal microbiota (Red)
0
HGVST1387 plus GWAS of Glaucoma (primary open-angle) 
  • Glaucoma (primary open-angle)
0
HGVST1388 plus GWAS of Stroke (pediatric) 
  • Stroke (pediatric) (Nonvascular)
  • Stroke (pediatric) (All)
0
HGVST1389 plus GWAS of Breast cancer (male) 
  • Breast cancer (male)
0
HGVST1390 plus GWAS of Breast cancer 
  • Breast cancer
0
HGVST1391 plus GWAS of Schizophrenia 
  • Schizophrenia (EA)
  • Schizophrenia (All)
0
HGVST1392 plus GWAS of Lung cancer 
  • Lung cancer
0
HGVST1379 plus GWAS of Resistin levels 
  • Resistin levels
0
HGVST1380 plus GWAS of Coronary heart disease 
  • Coronary heart disease
0
HGVST1381 plus GWAS of Orofacial clefts 
  • Orofacial clefts (Meta-All, NSCLO)
  • Orofacial clefts (Meta-All, NSCL/P)
  • Orofacial clefts (Meta-ALL, NSCL/P)
  • Orofacial clefts (Meta-All, NSCLP)
0
HGVST1382 plus GWAS of Lung adenocarcinoma 
  • Lung adenocarcinoma
0
HGVST1383 plus GWAS of Glioma 
  • Glioma
0
HGVST1384 plus GWAS of Sarcoidosis 
  • Sarcoidosis
0
HGVST1385 plus GWAS of Hepatitis C induced liver fibrosis 
  • Hepatitis C induced liver fibrosis (Binary F0-1/F3-4)
  • Hepatitis C induced liver fibrosis (Duration F0-1/F3-4, male)
  • Hepatitis C induced liver fibrosis (Duration F0-1/F3-4,>20yo)
  • Hepatitis C induced liver fibrosis (QTF)
  • Hepatitis C induced liver fibrosis (Binary F0/F4)
  • Hepatitis C induced liver fibrosis (Duration F0-1/F3-4, transfused)
0
HGVST1371 plus GWAS of Polycystic ovary syndrome 
  • Polycystic ovary syndrome
0
HGVST1372 plus GWAS of Response to citalopram treatment 
  • Response to citalopram treatment (EA + AA - GSE)
  • Response to citalopram treatment (EA + AA - Vision\hearing)
  • Response to citalopram treatment (EA - Overall tolerability)
  • Response to citalopram treatment (EA + AA - Overall tolerability)
  • Response to citalopram treatment (EA + AA - Dizziness)
  • Response to citalopram treatment (AA - GSE)
  • Response to citalopram treatment (EA - GSE)
  • Response to citalopram treatment (AA - Dizziness)
  • Response to citalopram treatment (AA - Vision\hearing)
0
HGVST1373 plus GWAS of Sclerosing cholangitis and ulcerative colitis (combined) 
  • Sclerosing cholangitis and ulcerative colitis (combined) (PSC)
0
HGVST1374 plus GWAS of Antineutrophil cytoplasmic antibody-associated vasculitis 
  • Antineutrophil cytoplasmic antibody-associated vasculitis
18
HGVST1375 plus GWAS of C-reactive protein and white blood cell count 
  • C-reactive protein and white blood cell count (WBC)
  • C-reactive protein and white blood cell count (CRP)
0
HGVST1376 plus GWAS of Aging 
  • Aging
0